FindTrial
Sign In

Endocrine Dysfunction in Thalassemia patients on regular blood transfusions

To study Endocrinological Dysfunction in Transfusion dependent Thalassemia Patients with Iron Overload

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/052925
Enrollment
75
Registered
2023-05-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D561- Beta thalassemia

Interventions

None listed

Sponsors

Dept of Internal Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Transfusion dependent males and females with Thalassemia. History of at least 05 years of chronic transfusion defined as cumulative transfusion load more than 50 ml/kg body weight

Exclusion criteria

Exclusion criteria: Pregnant women or lactating women during study enrolment

Design outcomes

Primary

MeasureTime frame
Incidence of endocrinological dysfunction in Chronic transfusion-dependent patients with ThalassemiaTimepoint: Cross-sectional Single time evaluation—

Secondary

MeasureTime frame
Correlation of the Endocrine dysfunction with the Transfusion loadTimepoint: Cross-sectional single time evaluation—

Countries

India

Contacts

Public ContactDr Abhishek Aravind

Armed Forces Medical College

udayj2yanamandra@gmail.com8195035551

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026